Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression

Journal of Experimental Medicine

Volumn 191, Issue 8, 2000, Pages 1423-1428

  Yin, Deling ^a   Tuthill, David ^a   Mufson, R Allan ^b   Shi, Yufang ^a  

^a HOLLAND LABORATORY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Endogenous opioid; Fas antigen; Lymphocyte; Stress

Indexed keywords

FAS ANTIGEN; HORMONE; NALOXONE; NALTREXONE; NEUROTRANSMITTER;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HORMONE RELEASE; HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; LYMPHOCYTE; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PHYSICAL STRESS; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; DNA, ANTISENSE; FAS LIGAND PROTEIN; GENE EXPRESSION; HUMANS; LIGANDS; LYMPHOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; RESTRAINT, PHYSICAL; STRESS; TRANSFECTION;

EID: 0034678451     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.8.1423     Document Type: Article

References (39)

1. Stone, A.A., and D.H. Bovbjerg. 1994. Stress and humoral immunity: a review of the human studies. Adv. Neuroimmunol. 4:49-56.
2. Wilder, R.L. 1995. Neuroendocrine-immune system interactions and autoimmunity. Annu. Rev. Immunol. 13:307-338.
3. Gonzalez-Quijano, M.I., M. Martin, S. Millan, and A. Lopez-Calderon. 1998. Lymphocyte response to mitogens: influence of life events and personality. Neuropsychobiology. 38: 90-96.
4. Husband, A.J. 1993. Role of central nervous system and behaviour in the immune response. Vaccine. 11:805-816.
5. Pedersen, B.K., and D.C. Nieman. 1998. Exercise immunology: integration and regulation. Immunol. Today. 19:204-206.
6. Spangelo, B.L., and W.C. Gorospe. 1995. Role of the cytokines in the neuroendocrine-immune system axis. Frout. Neuroendocrinol. 16:1-22.
7. Bai, Y., and R.P. Hart. 1998. Cultured sympathetic neurons express functional interleukin-1 receptors. J. Neuroimmunol. 91:43-54.
8. Marz, P., J.G. Cheng, R.A. Gadient, P.H. Patterson, T. Stoyan, U. Otten, and S. Rose-John. 1998. Sympathetic neurons can produce and respond to interleukin 6. Proc. Natl. Acad. Sci. USA. 95:3251-3256.
9. Gaillard, R.C. 1998. Cytokines in the neuroendocrine system. Int. Rev. Immunol. 17:181-216.
10. Nieman, D.C. 1997. Exercise immunology: practical applications. Int. J. Sports Med. 18(Suppl.) 1:S91-S100.
11. Nieman, D.C., and B.K. Pedersen. 1999. Exercise and immune function. Recent developments. Sports Med. 27:73-80.
12. Dhabhar, F.S., and B.S. McEwen. 1997. Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav. Immun. 11:286-306.
13. Dhabhar, F.S., and B.S. McEwen. 1999. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. USA. 96:1059-1064.
14. Ader, R., and N. Cohen. 1993. Psychoneuroimmunology: conditioning and stress. Annu. Rev. Psychol. 44:53-85.
15. Sklar, L.S., and H. Anisman. 1979. Stress and coping factors influence tumor growth. Science. 205:513-515.
16. Temoshok, L. 1987. Personality, coping style, emotion and cancer: towards an integrative model. Cancer Surv. 6:545-567.
17. Shanks, N., and A.W. Kusnecov. 1998. Differential immune reactivity to stress in BALB/cByJ and C57BL/6J mice: in vivo dependence on macrophages. Physiol. Behav. 65:95-103.
18. Olson, G.A., R.D. Olson, A.L. Vaccarino, and A.J. Kastin. 1998. Endogenous opiates: 1997. Peptides. 19:1791-1843.
19. Sheridan, J.F., C. Dobbs, J. Jung, X. Chu, A. Konstantinos, D. Padgett, and R. Glaser. 1998. Stress-induced neuroendocrine modulation of viral pathogenesis and immunity. Ann. NY Acad. Sci. 840:803-808.
20. O'Leary, A. 1990. Stress, emotion, and human immune function. Psychol. Bull. 108:363-382.
21. Dhabhar, F.S., and B.S. McEwen. 1996. Stress-induced enhancement of antigen-specific cell-mediated immunity. J. Immunol. 156:2608-2615.
22. McEwen, B.S., C.A. Biron, K.W. Brunson, K. Bulloch, W.H. Chambers, F.S. Dhabhar, R.H. Goldfarb, R.P. Kitson, A.M. Miller, R.L. Spencer, and J.M. Weiss. 1997. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res. Brain Res. Rev. 23:79-133.
23. Nash, M.S. 1994. Exercise and immunology. Med. Sci. Sports Exerc. 26:125-127.
24. Persoons, J.H., F. Berkenbosch, K. Schornagel, T. Thepen, and G. Kraal. 1995. Increased specific IgE production in lungs after the induction of acute stress in rats. J. Allergy Clin. Immunol. 95:765-770.
25. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today. 16:39-43.
26. Brunner, T., R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Martin, W.R. Force, D.H. Lynch, C.F. Ware, et al. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature. 373:441-444.
27. Wallach, D. 1997. Apoptosis. Placing death under control. Nature. 388:123, 125-126.
28. Ju, S.T., D.J. Panka, H. Cui, R. Ettinger, M. el-Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 373:444-448.
29. Alderson, M.R., T.W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K.A. Schooley, R.G. Goodwin, C.A. Smith, F. Ramsdell, and D.H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
30. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science. 267:1449-1456.
31. Rozlog, L.A., J.K. Kiecolt-Glaser, P.T. Marucha, J.F. Sheridan, and R. Glaser. 1999. Stress and immunity: implications for viral disease and wound healing. J. Periodontol. 70:786-792.
32. Munck, A., and A. Naray-Fejes-Toth. 1994. Glucocorticoids and stress: permissive and suppressive actions. Ann. NY Acad. Sci. 746:115-130.
33. Sharp, B.M., S. Roy, and J.M. Bidlack. 1998. Evidence for opioid receptors on cells involved in host defense and the immune system. J. Neuroimmunol. 83:45-56.
34. Odio, M., and A. Brodish. 1990. Central but not peripheral opiate receptor blockade prolonged pituitary-adrenal responses to stress. Pharmacol. Biochem. Behav. 35:963-969.
35. Kowalski, J. 1998. Immunomodulatory action of class mu-, delta-and kappa-opioid receptor agonists in mice. Neuropeptides. 32:301-306.
36. Shavit, Y., J.W. Lewis, G.W. Terman, R.P. Gale, and J.C. Liebeskind. 1984. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science. 223: 188-190.
37. Yin, D., R.A. Mufson, R. Wang, and Y. Shi. 1999. Fas-mediated cell death promoted by opioids. Nature 397:218.
38. Padgett, D.A., J.F. Sheridan, J. Dorne, G.G. Berntson, J. Candelora, and R. Glaser. 1998. Social stress and the reactivation of latent herpes simplex virus type 1. Proc. Natl. Acad. Sci. USA. 95:7231-7235.
39. Chirmule, N., A.D. Moscioni, Y. Qian, R. Qian, Y. Chen, and J.M. Wilson. 1999. Fas-Fas ligand interactions play a major role in effector functions of cytotoxic T lymphocytes after adenovirus vector-mediated gene transfer. Hum. Gene Ther. 10:259-269.